Veeva Systems Inc.

VEEV Healthcare Health Information Services

Veeva Systems Inc.’s revenue for fiscal 2026 (year ended January 2026) was $3.2 billion, up 16.3% from fiscal 2025. In the quarter to July 2026, revenue grew 17.6%, EPS grew 36.6% and free cash flow was flat, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for ten consecutive years, operating cash flow growth for ten.

310.30 2.73 −0.87%
Market cap
$50.7B
P/E
50.0×
Fwd P/E
26.9×
Dividend yield
—
F-score
7/9
Altman Z
13.57
Beneish M
−2.63
Dividend safety
n/a

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Jan '17 Jan '18 Jan '19 Jan '20 Jan '21 Jan '22 Jan '23 Jan '24 Jan '25 Jan '26
Cash and Short Term Investments
518.87 761.96 1,090.16 1,086.75 1,663.63 2,376.10 3,102.63 4,027.76 5,150.23 6,560.81
Receivables
182.82 238.02 321.59 422.51 611.59 694.40 785.23 888.54 1,057.12 1,310.35
Other current assets
10.18 12.00 21.67 21.87 36.00 36.68 81.46 86.92 101.46 —
Total current assets
711.87 1,012.42 1,433.41 1,531.12 2,310.83 3,107.18 3,969.31 5,003.21 6,308.80 7,997.63
Property, Plant, Equpment (Net)
49.91 52.28 54.97 54.75 53.65 54.50 49.82 58.53 55.91 70.26
Goodwill and Intangible Assets (Total)
135.09 127.29 120.33 573.13 550.62 541.82 522.35 502.89 484.34 470.19
Long Term Assets (Tax, Deferred)
16.46 2.22 5.94 11.87 14.10 5.10 136.70 233.46 343.92 273.42
Long-term assets (Other)
4.06 5.81 8.25 16.18 17.88 25.13 38.96 43.30 56.54 62.26
Total non-current assets
205.51 217.91 220.35 740.65 735.24 709.28 834.98 907.71 1,030.95 981.71
Total Assets
917.38 1,230.33 1,653.77 2,271.78 3,046.07 3,816.47 4,804.30 5,910.92 7,339.76 8,979.34
Accounts Payable
5.68 6.94 9.11 19.42 23.25 20.35 41.68 31.51 30.45 37.64
Accrued Expenses
24.32 30.21 31.47 47.24 61.39 69.94 79.59 76.41 74.99 91.74
Current Part of Taxes to Pay
3.23 2.08 4.09 5.61 2.59 7.76 4.95 11.86 9.02 6.70
Current Revenue (Deferred)
213.56 266.94 356.36 468.89 616.99 731.75 869.29 1,049.76 1,273.98 1,488.82
Total current liabilities
246.78 306.17 401.02 551.17 715.95 840.78 1,006.80 1,178.88 1,398.40 1,637.06
Long Term Tax Liability (Deferred)
12.97 10.95 6.10 2.42 1.84 2.22 1.49 2.05 0.59 0.56
Non-current Liabilities (Other)
4.96 6.98 8.90 7.78 10.57 18.23 30.08 38.72 42.59 43.27
Total non-current liabilities
17.94 17.93 15.00 55.01 63.80 64.05 81.24 87.21 108.98 127.54
Total liabilities
264.72 324.10 416.02 606.18 779.75 904.83 1,088.04 1,266.10 1,507.38 1,764.59
Additional Paid In Capital
439.66 515.27 617.62 745.48 965.67 1,196.55 1,532.63 1,915.00 2,386.19 2,843.09
Common Stock (Net)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Retained Earnings
212.88 389.37 619.20 919.66 1,299.66 1,727.05 2,214.75 2,740.46 3,454.60 4,363.50
Common Equity (Total)
652.65 906.24 1,237.75 1,665.59 2,266.32 2,911.64 3,716.25 4,644.82 5,832.37 7,214.75
Shareholders Equity (Total)
652.65 906.24 1,237.75 1,665.59 2,266.32 2,911.64 3,716.25 4,644.82 5,832.37 7,214.75
Shareholders Equity and Liabilities (Total)
917.38 1,230.33 1,653.77 2,271.78 3,046.07 3,816.47 4,804.30 5,910.92 7,339.76 8,979.34
Shares (Common)
137.89 142.07 146.19 149.10 152.06 154.20 158.25 161.26 162.58 163.78
Shareholders Equity (Tangible)
517.57 778.94 1,117.42 1,092.46 1,715.70 2,369.82 3,193.90 4,141.93 5,348.04 6,744.56
Net Debt
(518.87) (761.96) (1,090.16) (1,086.75) (1,663.63) (2,376.10) (3,102.63) (4,027.76) (5,150.23) (6,560.81)
Total Debt
— — — 55.00 63.00 55.00 61.00 — — —

Fold the line items

In millions of $ except per-share values · columns are period end dates